Skip to content

Nervgen Pharma Corp.

NGEN· NasdaqCore metricsCIK 1751912

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · +20.00%
Market cap
$129.03M
79.65M shares
Filings
42
—
—
—
-CA$44.12M
FY 2025N/M FY25 yoy
—
—
—
—
—
—
-CA$0.61
FY 2025N/M FY25 yoy
CA$22.07M
FY 2025+27.8% FY25 yoy
$129.03M
—
—
—
—
—

Price

$1.6231.36%$0.74past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

CA$13.91MFY 2025
CA$15.81M0FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31CA$13,907,206reported
FY 20242024-12-31CA$15,811,020reported

Pharmaceutical preparations

Nervgen Pharma Corp. is the 273rd largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Nervgen Pharma Corp. · CIK 1751912 · Engraved from SEC EDGAR